Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Impact of Acetaminophen on Guardian Sensor 3
NCT04378114Completed
- Sponsor
- Medtronic
- Start
- May 2020
- Primary completion
- Jul 2020
- Countries
- 1
01
Overview
Open-label trial (2 arms), sponsored by Medtronic. Primary endpoint: Bias between Guardian Sensor (3) and YSI Plasma Glucose. Started May 2020; status: completed.
Beyond the preview
Go deeper on NCT04378114.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04378114.